Search

AxoGen Inc

Închisă

SectorSănătate

41.79 -0.14

Rezumat

Modificarea prețului

24h

Curent

Minim

41.61

Maxim

42.51

Indicatori cheie

By Trading Economics

Venit

18M

-1.5M

Vânzări

8.3M

70M

EPS

-0.03

Marjă de profit

-2.174

Angajați

622

EBITDA

15M

-2.2M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+30.16% upside

Dividende

By Acuity

Următoarele câștiguri

28 oct. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

408M

2.6B

Deschiderea anterioară

41.93

Închiderea anterioară

41.79

Sentimentul știrilor

By Acuity

50%

50%

126 / 339 Clasament în Healthcare

AxoGen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 sept. 2026, 20:13 UTC

AxoGen Inc shares are lower in after-market hours with no specific news identified. Recent inflation data has raised speculation about a Federal Reserve rate hike.

10 sept. 2026, 20:03 UTC

News
Social Media
Event

AxoGen Inc shares are lower after announcing a public offering of 4.91 million shares at $42.50 to fund its $200 million acquisition of BioCircuit Technologies.

8 sept. 2026, 20:07 UTC

News

AxoGen Inc shares are lower today, continuing a downward trend amid speculation of an interest rate hike following a stronger-than-expected jobs report.

3 sept. 2026, 19:56 UTC

AxoGen Inc shares are lower, extending a five-session decline amid broader market dynamics and a drop in Treasury yields following jobless claims data.

2 sept. 2026, 20:01 UTC

AxoGen Inc shares are lower today, marking four consecutive sessions of declines. Broader market sentiment is affected by a disappointing ADP employment report.

1 sept. 2026, 20:09 UTC

News

AxoGen Inc shares are lower today, continuing a decline since Monday amid rising oil prices and inflation concerns affecting the health care equipment sector.

31 aug. 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum despite no specific company news. Broader market sentiment is influenced by Fed Chair Warsh's remarks.

28 aug. 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting positive momentum. The stock is near the upper end of its one-month trading range.

27 aug. 2026, 19:56 UTC

News

AxoGen shares are higher as Bamco Inc. acquired 740,210 shares valued at $34.19 million in the second quarter, boosting institutional sentiment.

26 aug. 2026, 23:01 UTC

AxoGen Inc shares are higher in after-market trading, reflecting broader market trends and positive macroeconomic data indicating underlying economic strength.

25 aug. 2026, 19:46 UTC

AxoGen Inc shares are higher during Tuesday's session, reflecting upward momentum amid broader positive trends in equities and a favorable health care equipment sector.

24 aug. 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, maintaining gains since Monday's close and positioned near the upper end of their one-month range.

21 aug. 2026, 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20 aug. 2026, 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19 aug. 2026, 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18 aug. 2026, 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17 aug. 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14 aug. 2026, 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13 aug. 2026, 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12 aug. 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 aug. 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 aug. 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 aug. 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 aug. 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 aug. 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 iul. 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 iul. 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 iul. 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 iul. 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 iul. 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

Comparație

Modificare preț

AxoGen Inc Așteptări

Obiectiv de preț

By TipRanks

30.16% sus

Prognoză pe 12 luni

Medie 54.875 USD  30.16%

Maxim 60 USD

Minim 48 USD

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAxoGen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

8 ratings

8

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

126 / 339 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.
help-icon Live chat